Milestone PharmaceuticalsMIST
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 47 institutions reported holding Milestone Pharmaceuticals Inc. (MIST) in their 13F filings, up 4 from Q3 2024. 9 opened new positions and 5 sold out. The largest holders were BlackRock, Inc. ($9.6M), Millennium Management ($6.4M) and Alta Fundamental Advisers LLC ($6.3M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Milestone Pharmaceuticals Inc.
- CUSIP
- 59935V107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $2.5M |
| Exits | 5 | $775K |
All 13F filers, Q3 2024 → Q4 2024: 1,501,882 shares bought and 5,626,901 shares sold, net −4,125,019 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| BlackRock, Inc. | 0.00% | Reduce -18.5% | 4,050,686 | $9.6M |
| Millennium Management | 0.01% | Reduce -2.7% | 2,703,259 | $6.4M |
| Alta Fundamental Advisers LLC | 2.34% | No change | 2,658,589 | $6.3M |
| RTW Investments, LP | 0.09% | Reduce -23.0% | 2,506,102 | $5.9M |
| Orbimed Advisors LLC | 0.10% | No change | 2,000,000 | $4.7M |
| Nantahala Capital Management, LLC | 0.24% | Reduce -17.4% | 1,445,264 | $3.4M |
| Bleichroeder LP | 0.79% | No change | 1,326,085 | $3.1M |
| Morgan Stanley | 0.00% | Add +40.4% | 1,289,141 | $3.0M |
| BML Capital Management, LLC | 1.67% | No change | 1,136,091 | $2.7M |
| Lion Point Capital, LP | 12.68% | Reduce -38.0% | 1,025,806 | $2.4M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -30.4% | 942,407 | $2.2M |
| Toronto Dominion Bank | 0.00% | New | 750,000 | $1.8M |
| Citadel Advisors | 0.00% | Reduce -70.5% | 608,202 | $1.4M |
| Stonepine Capital Management, LLC | 0.95% | Reduce -50.0% | 500,000 | $1.2M |
| Ikarian Capital, LLC | 0.31% | Add +0.0% | 466,030 | $1.1M |
| Boxer Capital Management, LLC | 0.06% | — | 309,007 | $729K |
| UBS Group AG | 0.00% | New | 89,506 | $211K |
| Virtu Financial LLC | 0.01% | New | 71,955 | $170K |
| Envestnet Asset Management Inc. | 0.00% | Reduce -9.7% | 63,742 | $150K |
| Northern Trust Corp. | 0.00% | Add +112.6% | 58,108 | $137K |
| Squarepoint Ops LLC | 0.00% | Add +4.6% | 56,751 | $134K |
| Group One Trading LLC | 0.00% | New | 52,637 | $124K |
| Dimensional Fund Advisors LP | 0.00% | No change | 39,450 | $93K |
| Atria Investments, Inc | 0.00% | Reduce -4.3% | 38,666 | $91K |
| XTX Topco Ltd | 0.01% | New | 34,054 | $80K |
| Susquehanna International Group, LLP | 0.00% | New | 33,092 | $78K |
| BNP Paribas Financial Markets | 0.00% | Add +6.6% | 31,133 | $73K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 30,938 | $73K |
| Boothbay Fund Management, LLC | 0.00% | Add +0.0% | 30,790 | $73K |
| Cetera Investment Advisers | 0.00% | Add +0.2% | 24,731 | $58K |
| Valeo Financial Advisors, LLC | 0.00% | No change | 20,000 | $47K |
| Geode Capital Management, LLC | 0.00% | Add +13.1% | 19,872 | $47K |
| State Street Corp. | 0.00% | Reduce -1.0% | 19,117 | $45K |
| National Bank of Canada | 0.00% | Add +163.4% | 18,700 | $44K |
| Two Sigma Securities, LLC | 0.01% | Reduce -26.7% | 16,957 | $40K |
| Creative Planning | 0.00% | Add +8.4% | 14,180 | $33K |
| Beta Wealth Group, Inc. | 0.01% | No change | 14,127 | $33K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +23.8% | 13,000 | $31K |
| Jones Financial Companies LLLP | 0.00% | Add +1000.0% | 11,000 | $26K |
| Clear Creek Financial Management, LLC | 0.00% | Reduce -46.1% | 10,500 | $25K |
| Ancora Advisors LLC | 0.00% | Reduce -83.3% | 10,000 | $24K |
| Osaic Holdings, Inc. | 0.00% | Add +6.7% | 6,934 | $16K |
| Simplex Trading, LLC | 0.00% | Add +2069.2% | 4,642 | $10K |
| JPMorgan Chase & Co. | 0.00% | New | 900 | $2K |
| Citigroup Inc. | 0.00% | New | 329 | $776 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 100 | $236 |
| Barclays PLC | 0.00% | No change | 100 | $236 |
"% of holder's portfolio" is MIST's weight in each manager's 13F, not the share of Milestone Pharmaceuticals Inc. the manager owns.